Oragenics OGEN
NYSE OGEN
$0.43 +0.00 (+0.53%)
As of: Oct 21, 2026 · 11:16 AM EDT

Oragenics (OGEN) Receivables - Other (2021 - 2023)

Updated

Oragenics (OGEN) recorded Receivables - Other of $35,104 in Q3 2023, up 166.7% from the prior quarter.

Analysis

Oragenics (OGEN) Receivables - Other (2021 - 2023) Analysis & Trends

At the end of FY2021, Oragenics reported Receivables - Other of $6,987.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.26 Bn 19.71 Bn
2 Johnson & Johnson 614.28 Bn 532.81 Bn 17.26 Bn
3 AbbVie 503.23 Bn 476.34 Bn 12.70 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn
5 Novartis Ag 298.22 Bn 262.21 Bn 11.24 Bn
6 Astrazeneca 261.55 Bn 235.23 Bn 12.86 Bn
7 Amgen 235.92 Bn 191.31 Bn 7.24 Bn
8 Gilead Sciences 190.78 Bn 164.98 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 Oragenics 1.90 Mn -27.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 35,104.00
Jun 30, 2023 13,163.00
Dec 31, 2021 6,987.00
API Access

Oragenics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=OGEN&period=max&api_key=YOUR_API_KEY